Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Alembic Pharma gets USFDA nod for anti-influenza drug

      Alembic Pharma gets USFDA nod for anti-influenza drug

      supriya kashyap kashyap26 Jun 2017 11:29 AM IST
      New Delhi : Drug firm Alembic Pharmaceuticals has received US health regulators nod for Amantadine Hydrochloride capsules used to treat symptoms of...
      Fujifilm aims to double revenue from medical systems in India

      Fujifilm aims to double revenue from medical systems in India

      supriya kashyap kashyap26 Jun 2017 11:29 AM IST
      New Delhi : Japanese photography and imaging company Fujifilm is confident of doubling revenues from its medical systems business to over Rs 1,000...
      Nepal drugs watchdog asks Baba Ramdev’s Patanjali to recall six medicines

      Nepal drugs watchdog asks Baba Ramdev’s Patanjali to recall six medicines

      supriya kashyap kashyap26 Jun 2017 11:28 AM IST
      Kathmandu : Nepal's drugs watchdog has asked Ramdev's Patanjali Ayurveda to recall six Ayurvedic medicines after they were found to be of...
      DHL says USD 100 mln investment for GST solutions in India

      DHL says USD 100 mln investment for GST solutions in India

      supriya kashyap kashyap26 Jun 2017 9:39 AM IST
      Singapore : Global logistics group DHL, with plans to invest USD 100 million in coming years, is working with its customers to prepare for the Goods...
      Novo Nordisk says obesity drug helps up to 13.8 percent weight loss in phase 2 trial

      Novo Nordisk says obesity drug helps up to 13.8 percent weight loss in phase 2 trial

      supriya kashyap kashyap25 Jun 2017 9:13 AM IST
      Danish drugmaker Novo Nordisk said a phase 2 trial for its big hope in tackling obesity, an improved GLP-1 drug called semaglutide, showed a weight...
      Novartis breast cancer drug Kisqali wins European panel backing

      Novartis breast cancer drug Kisqali wins European panel backing

      supriya kashyap kashyap25 Jun 2017 9:11 AM IST
      Zurich : A European Medicines Agency (EMA) panel recommended approving Novartis's Kisqali drug, bolstering the Swiss drugmaker's bid to challenge...
      EU backs second biosimilar copy of Humira, worlds top drug

      EU backs second biosimilar copy of Humira, world's top drug

      supriya kashyap kashyap24 Jun 2017 9:11 AM IST
      European regulators have recommended approval of a second copy of AbbVie's rheumatoid arthritis drug Humira, the world's top-selling medicine, in a...
      FDA approves first treatment for a form of Batten disease

      FDA approves first treatment for a form of Batten disease

      supriya kashyap kashyap2 May 2017 11:15 AM IST
      The U.S. Food and Drug Administration approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first...
      Shobana Kamineni, Executive Vice Chairperson, Apollo Hospitals appointed new CII President

      Shobana Kamineni, Executive Vice Chairperson, Apollo Hospitals appointed new CII President

      supriya kashyap kashyap2 May 2017 11:10 AM IST
      The Confederation of Indian Industry (CII) announced new office-bearers for the year 2017-18. Ms Shobana Kamineni, Executive Vice Chairperson, Apollo...
      USFDA approves Takedas lung cancer drug as second-line treatment

      USFDA approves Takeda's lung cancer drug as second-line treatment

      supriya kashyap kashyap1 May 2017 11:36 AM IST
      Japan's Takeda Pharmaceutical Co Ltd said that the U.S. Food and Drug Administration approved its lung cancer drug, almost three months after the...
      Global medical-tech firms, India locked in tussle after stent price sting

      Global medical-tech firms, India locked in tussle after stent price sting

      supriya kashyap kashyap30 April 2017 12:12 PM IST
      New Delhi/Mumbai : A group of global medical-technology companies plans to tell Indian officials next month that any further price control measures...
      Lupin gets three observations from USFDA for Goa plant

      Lupin gets three observations from USFDA for Goa plant

      supriya kashyap kashyap30 April 2017 10:25 AM IST
      New Delhi : Drug firm Lupin said the US health regulator FDA has issued three observations after inspecting its Goa plant."Recently the company's...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok